Senior Vice President, Clinical Development
Dr. Madhuri Vusirikala brings more than two decades of leadership and clinical research experience in hematology, oncology, bone marrow transplantation, and cellular therapies.
She completed her medical and specialty training in Internal Medicine, Hematology, Oncology, and Bone Marrow Transplantation at SUNY Syracuse, the University of Pittsburgh, and Vanderbilt University Medical Center. Throughout her academic career, she served as a principal investigator on Phase I-III clinical trials and led stem cell transplantation and National Marrow Donor Program initiatives at UT Southwestern Medical Center. A recognized leader in the field, Dr. Vusirikala has authored or co-authored more than 150 peer-reviewed publications and remains an active member of the American Society of Hematology (ASH) and the American Society for Transplantation and Cellular Therapy (ASTCT).
As Senior Vice President of Clinical Development at Therakos, Dr. Vusirikala leads the company’s Clinical and Regulatory departments, driving development strategy and regulatory execution across the portfolio. Prior to joining Therakos, she served as Vice President of Clinical Development and Head of the Hematology Portfolio at Actinium Pharmaceuticals, where she directed clinical strategy, trial design and execution, regulatory interactions, translational research initiatives, and key academic collaborations.
Dr. Vusirikala earned her medical degree in India and completed advanced clinical and research training at several of the nation’s leading academic medical centers, establishing a distinguished career dedicated to advancing innovative therapies for patients with serious hematologic and immune-mediated diseases.